The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 25, 2018

Filed:

Sep. 22, 2016
Applicant:

Engen Bio, Inc., Redwood City, CA (US);

Inventors:

Mark Alfenito, Redwood City, CA (US);

Mark Baer, San Francisco, CA (US);

Doris Bucher, New York, NY (US);

Geoffrey Yarranton, Burlingame, CA (US);

Assignee:

EnGen Bio, Inc., Redwood City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); C07K 16/10 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); C07K 16/1018 (2013.01); A61K 2039/505 (2013.01); A61K 2039/55 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/6081 (2013.01); C07K 2317/34 (2013.01); C07K 2317/76 (2013.01); C12N 2760/16134 (2013.01);
Abstract

The present invention is directed generally to M1 polypeptides that can be utilized as vaccines and/or antigens for generation of anti-M1 polypeptide antibodies for prophylactic treatment of individuals who are susceptible to infection by influenza virus. The anti-M1 polypeptide antibodies of the invention are useful for treatment of individuals infected with influenza virus, or useful for prophylactic treatment of individuals who are susceptible to infection by influenza virus, or for immune-suppressed individuals who cannot generate an effective antibody response.


Find Patent Forward Citations

Loading…